vs
NOVAVAX INC（NVAX）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是NOVAVAX INC的1.4倍（$212.2M vs $147.3M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 11.9%，领先6.9%），NOVAVAX INC同比增速更快（66.8% vs 8.6%），过去两年NOVAVAX INC的营收复合增速更高（25.3% vs 11.1%）
诺瓦瓦克斯是一家总部位于美国马里兰州盖瑟斯堡的生物科技企业，专注于传染病疫苗研发。其开发的新冠疫苗现由赛诺菲负责商业化，同时还在布局流感、呼吸道合胞病毒（RSV）、禽流感、带状疱疹、艰难梭菌感染、疟疾等多个领域的疫苗管线。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
NVAX vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.4倍
$147.3M
营收增速更快
NVAX
高出58.3%
8.6%
净利率更高
RAMP
高出6.9%
11.9%
两年增速更快
NVAX
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $147.3M | $212.2M |
| 净利润 | $17.5M | $39.9M |
| 毛利率 | 85.0% | 71.9% |
| 营业利润率 | 9.7% | 18.6% |
| 净利率 | 11.9% | 18.8% |
| 营收同比 | 66.8% | 8.6% |
| 净利润同比 | 121.6% | 255.7% |
| 每股收益（稀释后） | $0.28 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVAXRAMP
| Q4 25 | $147.3M | $212.2M | ||
| Q3 25 | $70.4M | $199.8M | ||
| Q2 25 | $239.2M | $194.8M | ||
| Q1 25 | $666.5M | $188.7M | ||
| Q4 24 | $88.3M | $195.4M | ||
| Q3 24 | $84.5M | $185.5M | ||
| Q2 24 | $415.5M | $176.0M | ||
| Q1 24 | $93.9M | $171.9M |
净利润NVAXRAMP
| Q4 25 | $17.5M | $39.9M | ||
| Q3 25 | $-202.4M | $27.4M | ||
| Q2 25 | $106.5M | $7.7M | ||
| Q1 25 | $518.6M | $-6.3M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $-121.3M | $1.7M | ||
| Q2 24 | $162.4M | $-7.5M | ||
| Q1 24 | $-147.6M | $-5.4M |
毛利率NVAXRAMP
| Q4 25 | 85.0% | 71.9% | ||
| Q3 25 | 69.5% | 70.2% | ||
| Q2 25 | 93.6% | 70.1% | ||
| Q1 25 | 97.9% | 69.3% | ||
| Q4 24 | 58.5% | 71.9% | ||
| Q3 24 | 28.3% | 72.4% | ||
| Q2 24 | 88.9% | 70.6% | ||
| Q1 24 | 36.9% | 72.2% |
营业利润率NVAXRAMP
| Q4 25 | 9.7% | 18.6% | ||
| Q3 25 | -252.7% | 10.7% | ||
| Q2 25 | 42.2% | 3.7% | ||
| Q1 25 | 77.4% | -6.1% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | -158.6% | 4.0% | ||
| Q2 24 | 38.7% | -3.0% | ||
| Q1 24 | -154.3% | -8.3% |
净利率NVAXRAMP
| Q4 25 | 11.9% | 18.8% | ||
| Q3 25 | -287.3% | 13.7% | ||
| Q2 25 | 44.5% | 4.0% | ||
| Q1 25 | 77.8% | -3.3% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | -143.5% | 0.9% | ||
| Q2 24 | 39.1% | -4.3% | ||
| Q1 24 | -157.2% | -3.1% |
每股收益（稀释后）NVAXRAMP
| Q4 25 | $0.28 | $0.62 | ||
| Q3 25 | $-1.25 | $0.42 | ||
| Q2 25 | $0.62 | $0.12 | ||
| Q1 25 | $2.93 | $-0.10 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | $-0.76 | $0.03 | ||
| Q2 24 | $0.99 | $-0.11 | ||
| Q1 24 | $-1.05 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $735.1M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-127.8M | $962.3M |
| 总资产 | $1.2B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVAXRAMP
| Q4 25 | $735.1M | $403.4M | ||
| Q3 25 | $762.9M | $376.9M | ||
| Q2 25 | $612.3M | $371.1M | ||
| Q1 25 | $731.5M | $420.8M | ||
| Q4 24 | $923.1M | $384.3M | ||
| Q3 24 | $909.5M | $348.4M | ||
| Q2 24 | $1.0B | $342.7M | ||
| Q1 24 | $480.6M | $368.9M |
股东权益NVAXRAMP
| Q4 25 | $-127.8M | $962.3M | ||
| Q3 25 | $-156.7M | $943.8M | ||
| Q2 25 | $37.6M | $947.8M | ||
| Q1 25 | $-75.6M | $948.9M | ||
| Q4 24 | $-623.8M | $957.7M | ||
| Q3 24 | $-526.4M | $932.1M | ||
| Q2 24 | $-431.7M | $951.9M | ||
| Q1 24 | $-867.1M | $949.1M |
总资产NVAXRAMP
| Q4 25 | $1.2B | $1.3B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.7B | $1.2B | ||
| Q2 24 | $1.8B | $1.2B | ||
| Q1 24 | $1.4B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-41.6M | — |
| 自由现金流率自由现金流/营收 | -28.2% | — |
| 资本支出强度资本支出/营收 | 1.4% | 0.1% |
| 现金转化率经营现金流/净利润 | -2.25× | — |
| 过去12个月自由现金流最近4个季度 | $-250.2M | — |
8季度趋势，按日历期对齐
经营现金流NVAXRAMP
| Q4 25 | $-39.5M | — | ||
| Q3 25 | $107.8M | $57.4M | ||
| Q2 25 | $-127.5M | $-15.8M | ||
| Q1 25 | $-185.5M | — | ||
| Q4 24 | $-87.3M | $45.1M | ||
| Q3 24 | $-144.8M | $55.6M | ||
| Q2 24 | $314.3M | $-9.3M | ||
| Q1 24 | $-83.6M | — |
自由现金流NVAXRAMP
| Q4 25 | $-41.6M | — | ||
| Q3 25 | $105.8M | $56.8M | ||
| Q2 25 | $-127.7M | $-16.2M | ||
| Q1 25 | $-186.7M | — | ||
| Q4 24 | $-100.3M | $44.8M | ||
| Q3 24 | $-146.2M | $55.4M | ||
| Q2 24 | $311.4M | $-9.6M | ||
| Q1 24 | $-90.4M | — |
自由现金流率NVAXRAMP
| Q4 25 | -28.2% | — | ||
| Q3 25 | 150.2% | 28.4% | ||
| Q2 25 | -53.4% | -8.3% | ||
| Q1 25 | -28.0% | — | ||
| Q4 24 | -113.6% | 22.9% | ||
| Q3 24 | -173.0% | 29.8% | ||
| Q2 24 | 74.9% | -5.4% | ||
| Q1 24 | -96.4% | — |
资本支出强度NVAXRAMP
| Q4 25 | 1.4% | 0.1% | ||
| Q3 25 | 2.9% | 0.3% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.2% | 0.2% | ||
| Q4 24 | 14.8% | 0.1% | ||
| Q3 24 | 1.6% | 0.1% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 7.3% | 1.0% |
现金转化率NVAXRAMP
| Q4 25 | -2.25× | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | -1.20× | -2.04× | ||
| Q1 25 | -0.36× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | 1.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
RAMP
暂无分部数据
